Physician profile
Amjad M Alkaed
NPI 1588629315
$253.20
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $15.78 · 2021: $32.45 · 2022: $22.94 · 2023: $14.99 · 2024: $52.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $77.35 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $60.49 | 2019-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $30.99 | 2023-2024 | Qelbree, Qelbree |
| Biomarin Pharmaceutical INC. | $22.94 | 2022 | |
| Sanofi Pasteur INC. | $20.63 | 2024 | |
| Vertical Pharmaceuticals, LLC | $14.13 | 2019 | |
| Shire North American Group INC | $11.15 | 2019 | |
| Glaxosmithkline, LLC. | $11.11 | 2019 | |
| Corium, LLC | $4.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amjad Alkaed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.